Evidence map›Paper›PMID 42898679›Full record

ReviewCancer communications (London, England)2026

Spatiotemporal Analysis of Molecular Continuity in Pathogenesis of Squamous Cell Carcinoma: From Normal Epithelium to Precancerous Lesions and Carcinoma.

Lan Lan, Xinyu Wang, Xiaoqi Jiang, Xiangyi Lin, Yancheng Lai, Wen Tan, Shaosen Zhang, Dongxin Lin, Chen Wu

Abstract readReview
In one paragraph

Review in Cancer communications (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lan LanDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Xinyu WangDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Xiaoqi JiangDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Xiangyi LinDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Yancheng LaiDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Wen TanDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Shaosen ZhangDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Dongxin LinDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.
Chen WuDepartment of Etiology and Carcinogenesis, National Cancer Center/National Clinical Research Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Squamous cell carcinomas (SCCs) develop from the stratified epithelia of the esophagus, head and neck, lung, and skin, providing a tractable model to investigate how altered epithelial fields progress toward invasive cancer. Across SCC subtypes, evolution often begins before overt malignancy, with age- and exposure-associated mutant clones expanding within histologically normal epithelia. As lesions advance, early driver selection becomes coupled to copy number alterations, chromosomal instability, and epigenetic remodeling, whereas later stages are shaped by branching diversification, cellular plasticity, and regionally constrained selection. Despite tissue-specific differences, several recurrent principles emerge, including clonal expansion within mutated normal fields, transition bottlenecks marked by genome-scale instability, and the spatial organization of subclonal architecture and invasive-front states. In this review, we synthesize recent progress in the temporal ordering and spatial patterning of SCC evolution and discuss how genetic alterations, epigenetic remodeling, and tissue ecology jointly drive disease progression. We further highlight the implications for early interception, biomarker development, immune evasion, and evolution-informed prevention and therapy.

Indexed as

Carcinoma, Squamous CellPrecancerous ConditionsAnimalsDisease ProgressionEpigenesis, GeneticEpitheliumHumansSpatio-Temporal Analysis

Identifiers

PMID42898679
PMCPMC13678079

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.